Belgian Observational Drug Utilization Study of Pimecrolimus Cream 1% in Routine Daily Practice in Atopic Dermatitis

Publisher： Karger

E-ISSN： 1421-9832|217|2|156-163

ISSN： 1018-8665

Source： Dermatology, Vol.217, Iss.2, 2008-06, pp. : 156-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Steroid-Sparing Effect of Pimecrolimus Cream 1% in Children with Severe Atopic Dermatitis

By  

Dermatology, Vol. 215, Iss. 4, 2007-10 ,pp. : 325-330

Karger

Access to resources Recommend Favorite

Percutaneous Absorption of Pimecrolimus Is Not Increased in Patients with Moderate to Severe Atopic Dermatitis when Pimecrolimus Cream 1% Is Applied under Occlusion

By  

Dermatology, Vol. 221, Iss. 4, 2010-11 ,pp. : 342-351

Karger

Access to resources Recommend Favorite

Rosaceiform Dermatitis with Follicular Demodex after Treatment of Facial Atopic Dermatitis with 1% Pimecrolimus Cream

By  

Dermatology, Vol. 207, Iss. 2, 2003-08 ,pp. : 205-207

Karger

Access to resources Recommend Favorite

Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis

By  

Dermatology, Vol. 208, Iss. 4, 2004-06 ,pp. : 365-372

Karger

Access to resources Recommend Favorite

Influence of Pimecrolimus Cream 1% on Different Morphological Signs of Eczema in Infants with Atopic Dermatitis

By  

Dermatology, Vol. 209, Iss. 4, 2004-12 ,pp. : 314-320

Karger

Access to resources Recommend Favorite